Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article reviews the classification history of androgenic alopecia and highlights the need for further research to find effective hair growth medications.

This study observed that female androgenetic alopecia is common among Caucasian women, starting in the late 20s and peaking after age 50.

This study reported that weekly intramuscular dexpanthenol may improve quality of life and satisfaction with hair appearance in women with female pattern hair loss, with no side effects observed.

This study suggests obstructive sleep apnea may increase the risk of male-pattern baldness in men with a family history of hair loss, and links low serum transferrin saturation levels to both conditions.

This study found that the E2-ANGPT2 pathway is involved in hair follicle regulation and that ANGPT2 treatment increased hair density in modeled female pattern hair loss, suggesting potential therapeutic use.

This article discusses managing extensive hair loss with limited transplant options and suggests a frontal forelock-type pattern is effective for both already bald men and younger patients at risk; it reports no new clinical results.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

This study found that pumpkin seed oil significantly improved hair parameters in females with pattern hair loss, demonstrating potential as a treatment comparable to minoxidil 5% foam.

In this study, QR678® and QR678 Neo® injections significantly improved hair density and thickness in women with PCOS-related alopecia over eight sessions, with effects lasting over a year.

This study reports an association between the ESR2 gene variant rs10137185 and female-pattern hair loss in German patients.

This review discusses recent advances in the diagnosis and management of female pattern hair loss but reports no new clinical results.

This study found that premenopausal women with female pattern hair loss had a higher prevalence of metabolic syndrome compared to healthy controls.

Low androgen levels can still cause female pattern hair loss.

This article describes a technique for evaluating and treating the under-addressed temporal peak areas in hair restoration surgery to improve cosmetic harmony with the frontal hairline.

This article reviews potential therapeutic targets and comorbidities associated with male androgenetic alopecia, but reports no new clinical results; further study is needed for comprehensive management.

This study found that eczema/dermatitis was the most common skin disease among patients at Al Husseiny Teaching Hospital's dermatology outpatient clinic.

This case report describes a 56-year-old woman whose nonscarring alopecia, consistent with alopecia areata with follicular mucinosis, resolved completely after treatment with oral prednisone.

This review evaluates six primary studies on androgenetic alopecia treatments and suggests topical minoxidil or finasteride as first-line options, recommending further research into treatments and practice guidelines.

This article provides no abstract or new research findings on the androgenic pattern presentation of scarring and inflammatory alopecia.

This article discusses the challenges in diagnosing and treating diffuse hair loss in women and emphasizes the importance of distinguishing between androgenetic alopecia, chronic telogen effluvium, and psychogenic pseudo effluvium, but reports no new clinical results.

This study found that while a modified BASP classification for pattern hair loss could classify previously unrecognized types, it was less accurate and harder to use than the existing BASP classification.

This study found that the TrichoScan software effectively differentiated between androgenetic alopecia and telogen effluvium in women with diffuse hair loss, aligning with clinical diagnoses.

This case report documents a rare instance of a female Indian patient with borderline-lepromatous leprosy experiencing generalized leprous alopecia of the scalp and lepromatous lymphadenitis of the suboccipital node.

This article reviews the causes, development, and treatment of diffuse alopecia, describing various external therapies and physiotherapy techniques.

This review discusses the pathogenesis and clinical features of androgenetic alopecia, highlighting potential links to fibrosing alopecia and suggesting the need for combined therapeutic approaches; it reports no new clinical results.

This article provides an overview of hair density, hair diameter, and the prevalence of female pattern hair loss but reports no new clinical findings.

This study examined the mental health of women with diffuse alopecia and found varied levels of mental maladjustment, with more patients with mixed alopecia showing adjustment disorders compared to those with metabolic alopecia. These findings could inform personalized treatment strategies for this condition.

This clinical study found that Rosmarinum officinalis mother tincture significantly improved hair volume and density in individuals with diffuse hair loss by enhancing hair parameters measured through a hair shedding visual scale and ponytail thickness test.

In this case report, two young women with female pattern hair loss experienced significant hair regrowth without adverse effects after six months of treatment with bone-marrow-derived mesenchymal stem cells and their extracellular vesicles, suggesting potential for this approach when conventional treatments fail.

In this case study, the authors explored the management of ophiasis, a rare and challenging form of alopecia areata, in a 3-year-old boy using the Unani system of medicine, aiming to provide insights for treatment approaches.